{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:48:17Z","timestamp":1771274897558,"version":"3.50.1"},"reference-count":27,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2022,8,31]]},"DOI":"10.5582\/bst.2022.01333","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T22:12:55Z","timestamp":1659219175000},"page":"312-316","source":"Crossref","is-referenced-by-count":39,"title":["Marburg virus disease: A deadly rare virus is coming"],"prefix":"10.5582","volume":"16","author":[{"given":"Fang","family":"Zhao","sequence":"first","affiliation":[{"name":"National Clinical Research Centre for Infectious Diseases, The Third People's Hospital of Shenzhen and the Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, Guangdong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"He","sequence":"additional","affiliation":[{"name":"National Clinical Research Centre for Infectious Diseases, The Third People's Hospital of Shenzhen and the Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, Guangdong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhou","family":"Lu","sequence":"additional","affiliation":[{"name":"National Clinical Research Centre for Infectious Diseases, The Third People's Hospital of Shenzhen and the Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, Guangdong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Amman BR, Bird BH, Bakarr IA, <i>et al<\/i>. Isolation of Angola-like Marburg virus from Egyptian rousette bats from West Africa. Nat Commun. 2020; 11:510.","DOI":"10.1038\/s41467-020-14327-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. King LB, West BR, Schendel SL, Saphire EO. The structural basis for filovirus neutralization by monoclonal antibodies. Curr Opin Immunol. 2018; 53:196-202.","DOI":"10.1016\/j.coi.2018.05.001"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Siegert R, Shu HL, Slenczka W. Isolation and identification of the &quot;Marburg virus&quot;. Dtsch Med Wochenschr. 1968; 93:604-612. ( in German)","DOI":"10.1055\/s-0028-1105103"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Slenczka W, Klenk HD. Forty years of marburg virus. J Infect Dis. 2007; 196 Suppl 2:S131-135.","DOI":"10.1086\/520551"},{"key":"5","unstructured":"5. Nikiforov VV, Turovskii Iu I, Kalinin PP, <i>et al<\/i>. A case of a laboratory infection with Marburg fever. Zh Mikrobiol Epidemiol Immunobiol. 1994;104-106. (in Russian)"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Towner JS, Amman BR, Sealy TK, <i>et al<\/i>. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog. 2009; 5:e1000536.","DOI":"10.1371\/journal.ppat.1000536"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pigott DM, Golding N, Mylne A, Huang Z, Weiss DJ, Brady OJ, Kraemer MU, Hay SI. Mapping the zoonotic niche of Marburg virus disease in Africa. Trans R Soc Trop Med Hyg. 2015; 109:366-378.","DOI":"10.1093\/trstmh\/trv024"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Pavlin BI. Calculation of incubation period and serial interval from multiple outbreaks of Marburg virus disease. BMC Res Notes. 2014; 7:906.","DOI":"10.1186\/1756-0500-7-906"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Marzi A, Jankeel A, Menicucci AR, Callison J, O&apos;Donnell KL, Feldmann F, Pinski AN, Hanley PW, Messaoudi I. Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease. Front Immunol. 2021; 12:774026.","DOI":"10.3389\/fimmu.2021.774026"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Anywaine Z, Barry H, Anzala O, <i>et al<\/i>. Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial. PLoS Med. 2022; 19:e1003865.","DOI":"10.1371\/journal.pmed.1003865"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cross RW, Bornholdt ZA, Prasad AN, <i>et al<\/i>. Combination therapy protects macaques against advanced Marburg virus disease. Nat Commun. 2021; 12:1891.","DOI":"10.1038\/s41467-021-22132-0"},{"key":"12","unstructured":"12. Centers for Disease C, Prevention. Imported case of Marburg hemorrhagic fever \u2012 Colorado, 2008. MMWR Morb Mortal Wkly Rep. 2009; 58:1377-1381."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Timen A, Koopmans MP, Vossen AC, van Doornum GJ, Gunther S, van den Berkmortel F, Verduin KM, Dittrich S, Emmerich P, Osterhaus AD, van Dissel JT, Coutinho RA. Response to imported case of Marburg hemorrhagic fever, the Netherland. Emerg Infect Dis. 2009; 15:1171-1175.","DOI":"10.3201\/eid1508.090015"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Swenson DL, Warfield KL, Larsen T, Alves DA, Coberley SS, Bavari S. Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses. Expert Rev Vaccines. 2008; 7:417-429.","DOI":"10.1586\/14760584.7.4.417"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Geisbert TW, Bailey M, Geisbert JB, Asiedu C, Roederer M, Grazia-Pau M, Custers J, Jahrling P, Goudsmit J, Koup R, Sullivan NJ. Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates. J Virol. 2010; 84:10386-10394.","DOI":"10.1128\/JVI.00594-10"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Riemenschneider J, Garrison A, Geisbert J, <i>et al<\/i>. Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus. Vaccine. 2003; 21:4071-4080.","DOI":"10.1016\/S0264-410X(03)00362-1"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Dye JM, Herbert AS, Kuehne AI, Barth JF, Muhammad MA, Zak SE, Ortiz RA, Prugar LI, Pratt WD. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc Natl Acad Sci U S A. 2012; 109:5034-5039.","DOI":"10.1073\/pnas.1200409109"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Porter DP, Weidner JM, Gomba L, <i>et al<\/i>. Remdesivir (GS-5734) Is Efficacious in Cynomolgus Macaques Infected With Marburg Virus. J Infect Dis. 2020; 222:1894-1901.","DOI":"10.1093\/infdis\/jiaa290"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Bixler SL, Bocan TM, Wells J, <i>et al<\/i>. Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus. Antiviral Res. 2018; 151:97-104.","DOI":"10.1016\/j.antiviral.2017.12.021"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Zhu W, Zhang Z, He S, Wong G, Banadyga L, Qiu X. Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model. Antiviral Res. 2018; 151:39-49.","DOI":"10.1016\/j.antiviral.2018.01.011"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Warren TK, Whitehouse CA, Wells J, Welch L, Charleston JS, Heald A, Nichols DK, Mattix ME, Palacios G, Kugleman JR, Iversen PL, Bavari S. Delayed Time-to-Treatment of an Antisense Morpholino Oligomer Is Effective against Lethal Marburg Virus Infection in Cynomolgus Macaques. PLoS Negl Trop Dis. 2016; 10:e0004456.","DOI":"10.1371\/journal.pntd.0004456"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Heald AE, Iversen PL, Saoud JB, Sazani P, Charleston JS, Axtelle T, Wong M, Smith WB, Vutikullird A, Kaye E. Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against ebola virus and marburg virus: results of two single-ascending-dose studies. Antimicrob Agents Chemother. 2014; 58:6639-6647.","DOI":"10.1128\/AAC.03442-14"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Heald AE, Charleston JS, Iversen PL, <i>et al<\/i>. AVI-7288 for Marburg Virus in Nonhuman Primates and Humans. N Engl J Med. 2015; 373:339-348.","DOI":"10.1056\/NEJMoa1410345"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Thi EP, Mire CE, Ursic-Bedoya R, Geisbert JB, Lee ACH, Agans KN, Robbins M, Deer DJ, Fenton KA, MacLachlan I, Geisbert TW. Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA. Sci Transl Med. 2014; 6:250ra116.","DOI":"10.1126\/scitranslmed.3009706"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. King LB, Fusco ML, Flyak AI, Ilinykh PA, Huang K, Gunn B, Kirchdoerfer RN, Hastie KM, Sangha AK, Meiler J, Alter G, Bukreyev A, Crowe JE, Jr., Saphire EO. The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding. Cell Host Microbe. 2018; 23:101-109 e104.","DOI":"10.1016\/j.chom.2017.12.003"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Mire CE, Geisbert JB, Borisevich V, <i>et al<\/i>. Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody. Sci Transl Med. 2017; 9.","DOI":"10.1126\/scitranslmed.aai8711"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kortepeter MG, Dierberg K, Shenoy ES, Cieslak TJ, Medical Countermeasures Working Group of the National Ebola T, Education Center&apos;s Special Pathogens Research N. Marburg virus disease: A summary for clinicians. Int J Infect Dis. 2020; 99:233-242.","DOI":"10.1016\/j.ijid.2020.07.042"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/16\/4\/16_2022.01333\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T03:51:28Z","timestamp":1663386688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/16\/4\/16_2022.01333\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,31]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2022.01333","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,31]]},"article-number":"2022.01333"}}